NO20033854L - N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse - Google Patents

N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse

Info

Publication number
NO20033854L
NO20033854L NO20033854A NO20033854A NO20033854L NO 20033854 L NO20033854 L NO 20033854L NO 20033854 A NO20033854 A NO 20033854A NO 20033854 A NO20033854 A NO 20033854A NO 20033854 L NO20033854 L NO 20033854L
Authority
NO
Norway
Prior art keywords
norbuprenorphine
enyl
methods
Prior art date
Application number
NO20033854A
Other languages
English (en)
Other versions
NO20033854D0 (no
Inventor
Bruce E Reidenberg
Donna-Donigi Gale
Vinayak J Srinivasan
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO20033854D0 publication Critical patent/NO20033854D0/no
Publication of NO20033854L publication Critical patent/NO20033854L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20033854A 2001-03-02 2003-09-01 N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse NO20033854L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27281901P 2001-03-02 2001-03-02
PCT/US2002/006766 WO2002070524A2 (en) 2001-03-02 2002-03-04 N-but-3-enyl norbuprenorphine and its use as analgesic

Publications (2)

Publication Number Publication Date
NO20033854D0 NO20033854D0 (no) 2003-09-01
NO20033854L true NO20033854L (no) 2003-10-28

Family

ID=23041438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033854A NO20033854L (no) 2001-03-02 2003-09-01 N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse

Country Status (14)

Country Link
US (2) US7125884B2 (no)
EP (1) EP1368356A2 (no)
JP (1) JP2004538256A (no)
KR (1) KR20030088445A (no)
CN (1) CN1507448A (no)
BR (1) BR0207978A (no)
CA (1) CA2439859A1 (no)
IL (1) IL157662A0 (no)
MX (1) MXPA03007885A (no)
NO (1) NO20033854L (no)
NZ (1) NZ528241A (no)
RU (1) RU2003129531A (no)
WO (1) WO2002070524A2 (no)
ZA (1) ZA200307337B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
PT2326651E (pt) * 2008-07-30 2014-02-12 Purdue Pharma Lp Análogos de buprenorfina
DK2619212T3 (en) 2010-09-21 2016-03-21 Purdue Pharma Lp BUPRENORPHINANALOGER AS opioid receptor agonists and / or antagonists
AU2012324012A1 (en) * 2011-12-08 2013-06-27 Purdue Pharma L.P. Quaternized buprenorphine analogs
RU2506265C1 (ru) * 2012-08-21 2014-02-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Фторсодержащие производные тевинола и орвинола и способы их получения (варианты)
RU2503678C1 (ru) * 2012-08-21 2014-01-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) 7α-(1-ГИДРОКСИ-2,2,2-ТРИФТОРЭТИЛ)-17-МЕТИЛ-3,6-ДИМЕТОКСИ-4,5α-ЭПОКСИ-6α,14αЭТЕНОИЗОМОРФИНАН И СПОСОБ ЕГО ПОЛУЧЕНИЯ
JP6400592B2 (ja) 2012-11-09 2018-10-03 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
TW201434842A (zh) 2012-12-07 2014-09-16 Purdue Pharma Lp 丁基原啡因(buprenorphine)類似物類
EP2941431B1 (en) * 2012-12-28 2017-10-25 Purdue Pharma L.P. Substituted morphinans and the use thereof
JP6182620B2 (ja) 2013-01-31 2017-08-16 パーデュー、ファーマ、リミテッド、パートナーシップ ベンゾモルファン類似体およびその使用
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
EP3087073B1 (en) 2013-12-26 2018-07-04 Purdue Pharma LP 10-substituted morphinan hydantoins
US9656962B2 (en) 2013-12-26 2017-05-23 Purdue Pharma L.P. Ring-contracted morphinans and the use thereof
EP3087078B1 (en) 2013-12-26 2019-05-15 Purdue Pharma LP 7-beta-alkyl analogs of orvinols
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
WO2015099863A1 (en) 2013-12-27 2015-07-02 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
US10030021B2 (en) 2014-05-27 2018-07-24 Purdue Pharma L.P. Spirocyclic morphinans and use thereof
JP6360915B2 (ja) 2014-06-13 2018-07-18 パーデュー、ファーマ、リミテッド、パートナーシップ アザモルフィナン誘導体及びその使用
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6784186B1 (en) * 1998-01-29 2004-08-31 Roy W. Jackson Therapeutic compounds

Also Published As

Publication number Publication date
WO2002070524A3 (en) 2002-10-17
JP2004538256A (ja) 2004-12-24
NZ528241A (en) 2004-08-27
US20050192308A1 (en) 2005-09-01
CA2439859A1 (en) 2002-09-12
KR20030088445A (ko) 2003-11-19
NO20033854D0 (no) 2003-09-01
BR0207978A (pt) 2004-03-02
US20040087605A1 (en) 2004-05-06
RU2003129531A (ru) 2005-04-10
ZA200307337B (en) 2004-12-20
IL157662A0 (en) 2004-03-28
EP1368356A2 (en) 2003-12-10
MXPA03007885A (es) 2004-05-24
CN1507448A (zh) 2004-06-23
US7125884B2 (en) 2006-10-24
WO2002070524A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
NO20033387L (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
NO20042229L (no) Type 4-fosfodiestemseinhibitorer og anvendelse derav
IS7725A (is) Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
IS2867B (is) Neublastín sem tengt er fjölliðu og aðferðir við notkun þess
NO20030843D0 (no) Anordning og fremgangsmåte for kultivering
NO20023843L (no) Skumanordning og fremgangsmåte
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf
DK1441746T3 (da) Sammens tning og fremgangsmode
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
NO20042126L (no) Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner
DE60143766D1 (de) Dübel und verwendungsverfahren dafür

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application